EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

WHO assessment of the preclinical antifungal pipeline: evaluating innovation and preparedness in the face of emerging fungal threats

Valeria Gigante, Richard A Alm, Tamarie Rocke, Daniela Melchiorri, Alexandra M Cameron

The Lancet Microbe · 2026

DOI: 10.1016/j.lanmic.2025.101331 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2026. Verfasst von Valeria Gigante und 4 weiteren Autor:innen. Beteiligte Einrichtung: Antimicrobial Resistance Department, WHO, Geneva, Switzerland. Electronic address: gigantev@who.int. Hauptthemen laut MEDLINE: Antifungal Agents, Mycoses, Fungi. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: World Health Organization, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsMycosesFungiHumansAnimalsDrug Evaluation, PreclinicalWorld Health OrganizationDrug Resistance, FungalDrug Development

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Antimicrobial Resistance Department, WHO, Geneva, Switzerland. Electronic address: gigantev@who.int.
  • Antimicrobial Resistance Department, WHO, Geneva, Switzerland.
  • Antimicrobial Resistance Department, WHO, Geneva, Switzerland; Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.

Förderung

  • World Health Organization
  • European Commission

Zitieren

APA

Gigante, V., Alm, R. A., Rocke, T., Melchiorri, D., & Cameron, A. M. (2026). WHO assessment of the preclinical antifungal pipeline: evaluating innovation and preparedness in the face of emerging fungal threats. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101331

Vancouver

Gigante V, Alm RA, Rocke T, Melchiorri D, Cameron AM. WHO assessment of the preclinical antifungal pipeline: evaluating innovation and preparedness in the face of emerging fungal threats. The Lancet Microbe. 2026. doi:10.1016/j.lanmic.2025.101331

BibTeX
@article{Gigante2026,
  author = {Gigante, Valeria and Alm, Richard A and Rocke, Tamarie and Melchiorri, Daniela and Cameron, Alexandra M},
  title = {WHO assessment of the preclinical antifungal pipeline: evaluating innovation and preparedness in the face of emerging fungal threats},
  journal = {The Lancet Microbe},
  year = {2026},
  doi = {10.1016/j.lanmic.2025.101331}
}
Kostenlos starten →